These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1982761)

  • 81. Comparison of wet and dry aerosol salbutamol.
    Harrison BA; Pierce RJ
    Aust N Z J Med; 1983 Feb; 13(1):29-33. PubMed ID: 6576742
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparison of salmefamol with salbutamol aerosols in asthamatics.
    Sillett RW; Dash CH; McNicol MW
    Eur J Clin Pharmacol; 1976 Feb; 9(4):277-80. PubMed ID: 786693
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of inhaled salbutamol in primary pulmonary hypertension.
    Spiekerkoetter E; Fabel H; Hoeper MM
    Eur Respir J; 2002 Sep; 20(3):524-8. PubMed ID: 12358324
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [An evaluation of the bronchodilator response with beta agonists in patients with chronic obstructive pulmonary disease].
    Fernández Francés J; Izquierdo Alonso JL
    Arch Bronconeumol; 1995; 31(6):270-5. PubMed ID: 7627421
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Combination of oxitropium bromide and salbutamol in the treatment of asthma with pressurized aerosols.
    Laitinen LA; Poppius H
    Br J Dis Chest; 1986 Apr; 80(2):179-86. PubMed ID: 3730264
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The influence of theophylline on maximal response to salbutamol in severe chronic obstructive pulmonary disease.
    Barclay J; Whiting B; Addis GJ
    Eur J Clin Pharmacol; 1982; 22(5):389-93. PubMed ID: 7117350
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Intranasal salbutamol instillation in asthma attack.
    Weksler N; Brill S; Tarnapolski A; Gurman GM
    Am J Emerg Med; 1999 Nov; 17(7):686-8. PubMed ID: 10597090
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol ('Pulmadil') and 0.2 mg. salbutamol.
    Bianco S; Kamburoff PL; Prime FJ
    Curr Med Res Opin; 1975; 3(1):30-5. PubMed ID: 1116382
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Bronchodilating effects of natriuretic and vasorelaxant peptides compared to salbutamol in asthmatics.
    Flüge T; Fabel H; Wagner TO; Schneider B; Forssmann WG
    Regul Pept; 1995 Nov; 59(3):357-70. PubMed ID: 8577941
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparison of salbutamol Rotahaler with conventional pressurized aerosol.
    Hetzel MR; Clark TJ
    Clin Allergy; 1977 Nov; 7(6):563-8. PubMed ID: 589786
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bronchodilator effect of hexoprenaline aerosol in bronchial asthma and chronic bronchitis.
    Schonell M; Harris M; McMiken D; Jenne H; Evers R
    Med J Aust; 1977 Dec; 2(25):828-30. PubMed ID: 349325
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of salbutamol on performance in endurance cyclists.
    Norris SR; Petersen SR; Jones RL
    Eur J Appl Physiol Occup Physiol; 1996; 73(3-4):364-8. PubMed ID: 8781870
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Differing bioavailability of salbutamol metered-dose inhalers.
    Chhabra SK
    J Asthma; 1987; 24(4):215-8. PubMed ID: 3505536
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The protective effect of transdermal broxaterol on exercise-induced bronchoconstriction.
    Robuschi M; Scuri M; Spagnotto S; Gambaro G; Lodola E; Pisati R; Bianco S
    Eur J Clin Pharmacol; 1995; 47(5):465-6. PubMed ID: 7720771
    [No Abstract]   [Full Text] [Related]  

  • 96. Assessment of lung function on healthy children using an electronic spirometer and an air-flowmeter before and after inhalation of an adrenergic receptor stimulant.
    Dalén G; Kjellman B
    Acta Paediatr Scand; 1979 Jan; 68(1):103-8. PubMed ID: 153081
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.
    Baker JG; Shaw DE
    Handb Exp Pharmacol; 2024; 285():369-451. PubMed ID: 37709918
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
    Simone P; Borgia M; Torre L; Ventresca GP
    Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of a new bronchodilating compound (broxaterol) administered as a pressurized aerosol.
    Robuschi M; Simone P; Vaghi A; Ventresca GP; Bianco S
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):101-4. PubMed ID: 2881897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.